Passage Bio, Inc.
PASG
$4.94
$0.091.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.82M | -7.56M | -12.98M | -7.75M | -9.39M |
| Total Depreciation and Amortization | 25.00K | 129.00K | 177.00K | 181.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.42M | -77.00K | 4.12M | 611.00K | 937.00K |
| Change in Net Operating Assets | 34.00K | -5.48M | 2.21M | 2.10M | 1.95M |
| Cash from Operations | -9.18M | -12.99M | -6.48M | -4.85M | -6.33M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 20.00K | 0.00 | 0.00 | 585.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 20.00K | 0.00 | 0.00 | 585.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 9.00K | 0.00 | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 9.00K | 0.00 | 14.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.18M | -12.97M | -6.47M | -4.85M | -5.73M |